DSPE-PEG3400
DSPE-PEG3400 is a phospholipid-PEG polymer conjugate that can be used in drug delivery applications. DSPE-PEG3400 serves as a material for preparing nanocarriers, which is used to prolong blood circulation time, enhance stability and improve encapsulation efficiency.
For research use only. We do not sell to patients.
- CAS No.: 145035-96-7
- Formula: (C2H4O)nC43H86NO9P
- Molecular Weight:3400 (Average)
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
DSPE-PEG3400, as a component of PDT biomimetic liposomes (PB Lipo), contributes to the formation of stable, biocompatible liposomes with efficient ICG encapsulation, sustained drug release, and laser-triggered accelerated ICG release[1].
DSPE-PEG3400 stabilized poly-TTG-SS nanoparticles are taken up by human prostate cancer C4-2 cells in a time-dependent manner, with increasing intracellular accumulation observed from 1 h to 6 h of incubation[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 145035-96-7
-
Molecular Weight 3400 (Average)
-
Formula (C2H4O)nC43H86NO9P
-
SMILES
O=C(CCCCCCCCCCCCCCCCC)OCC(COP(O)(OCCNCCOCCO)=O)OC(CCCCCCCCCCCCCCCCC)=O.[n]
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Li T, et al. Photodynamic Biomimetic Liposomes Targeted to the Endoplasmic Reticulum Enhance Combined Immunotherapy for Triple-Negative Breast Cancer. ACS Appl Mater Interfaces. 2025;17(17):25112-25127. [Content Brief]
[2]. Li L, et al. Tumor-microenvironment responsive nano-carrier system for therapy of prostate cancer. J Mater Sci Mater Med. 2023;34(10):46. Published 2023 Sep 21. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
DSPE-PEG3400 Related Classifications
HY-143209B Related Classifications
Powered by Bioz